Back to Search
Start Over
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
- Source :
- Signal Transduction & Targeted Therapy; 3/17/2023, Vol. 8 Issue 1, p1-10, 10p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 20959907
- Volume :
- 8
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Signal Transduction & Targeted Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 162506868
- Full Text :
- https://doi.org/10.1038/s41392-023-01317-7